Azithromycin May Promote Cancer Relapse After Allogeneic Stem Cell Transplantation
Researchers evaluated immune and metabolic function from samples of patients in the ALLOZITHRO trial to determine how azithromycin increases relapse risk after ASCT.
Researchers evaluated immune and metabolic function from samples of patients in the ALLOZITHRO trial to determine how azithromycin increases relapse risk after ASCT.
The SAFER program is helping Ukrainian children with cancers and other blood disorders to continue their therapy in Ukraine at centers in Europe and North America.
Researchers sought to determine whether storing RBCs in a hypoxic environment would improve functional outcomes of RBCs in long-term storage.
Researchers sought to determine the incidence, nature, and consequences of oncologists’ experiences with workplace sexual harassment.
Researchers sought to determine factors limiting access to gene and CAR-T therapies for patients with hematologic disorders.
About half of patients with impaired seroconversion after the first dose of a COVID-19 vaccine still had low antibody levels after the second dose.
Researchers sought to determine whether extracorporeal photopheresis would be a safe treatment approach for children who have steroid-refractory cGVHD.
Using a large cohort over a period of 38 years, the researchers assessed thrombocytopenia and other clinical variables as predictors of outcomes in patients with antiphospholipid syndrome.
Researchers sought to determine methods for diagnosing and managing patients who develop coagulation disorders due to COVID-19 infection.